Elucid Bioimaging

Boston, MA · Privately Held (backing)

Developer of an imaging system designed to improve patient outcomes at a reduced cost by applying artificial intelligence to vascular diagnostic imaging. Elucid Bioimaging is based in Boston, MA. It was valued at $288 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $163 million across 3 recorded rounds; the latest was a $36.5 million early-stage round in Oct 2025.

PMV mark · valuation
$288.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$163.2M
Last round
Early Stage VC
Oct 2025
What is Elucid Bioimaging worth?
$288.0MPrivateMarketView mark · Oct 2026

Valued at $288.0M at its later-stage round, Oct 2025. Nothing has traded since.

Free account
More of Elucid Bioimaging with a free account
  • ·The complete investor list: 24 names
  • ·Watch Elucid Bioimaging: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Elucid Bioimaging funding history

3 rounds
DateRoundRaisedPost-money
Oct 2025Early Stage VC$36.5M▮
Oct 2023Later Stage VC$79.0M▮
Sep 2013Seed Round$375K▮
Unlock post-money valuations

Membership and data by Private Market View

Elucid Bioimaging valuation

Elucid Bioimaging was valued at $288 million at its later-stage round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Elucid Bioimaging raised?

Elucid Bioimaging has raised $163 million across 3 recorded rounds since 2013. The largest was a $79 million later-stage round in Oct 2023; the most recent was a $36.5 million early-stage round in Oct 2025.

Elucid Bioimaging has filed 2 Form Ds with the SEC since 2013, most recently in Nov 2023 ($79 million sold to 13 investors).

How Elucid Bioimaging's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Elucid Bioimaging, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Elucid Bioimaging

What is Elucid Bioimaging worth?
Elucid Bioimaging is valued at $288.0M as of Oct 2026. Valued at $288.0M at its later-stage round, Oct 2025. Nothing has traded since.
How much has Elucid Bioimaging raised?
Elucid Bioimaging has raised $163.2M in total funding across 3 recorded rounds.
When did Elucid Bioimaging last raise?
Elucid Bioimaging last raised in Oct 2025 (Early Stage VC), raising $36.5M.